Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The optimal cut-off value in fit-based colorectal cancer screening: An observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Research output: Contribution to journalReviewResearchpeer-review

  2. Randomized trial of cytoreductive surgery for relapsed ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Murat Gultekin
  • Sertac Ak
  • Ali Ayhan
  • Aleksandra Strojna
  • Andrei Pletnev
  • Anna Fagotti
  • Anna Myriam Perrone
  • B Emre Erzeneoglu
  • B Esat Temiz
  • Birthe Lemley
  • Burcu Soyak
  • Cathy Hughes
  • David Cibula
  • Dimitrios Haidopoulos
  • Donal Brennan
  • Edoardo Cola
  • Elzbieta van der Steen-Banasik
  • Esra Urkmez
  • Huseyin Akilli
  • Ignacio Zapardiel
  • Icó Tóth
  • Jalid Sehouli
  • Kamil Zalewski
  • Kiarash Bahremand
  • Luis Chiva
  • Mansoor Raza Mirza
  • Maria Papageorgiou
  • Novak Zoltan
  • Petra Adámková
  • Philippe Morice
  • Sonia Garrido-Mallach
  • Utku Akgor
  • Vasilis Theodoulidis
  • Zafer Arik
  • Karina D Steffensen
  • Christina Fotopoulou
View graph of relations

BACKGROUND: The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications.

METHODS: A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations.

FINDINGS: We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety.

INTERPRETATION: Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.

Original languageEnglish
JournalCancer Medicine
Issue number1
Pages (from-to)208-219
Number of pages12
Publication statusPublished - Jan 2021

Bibliographical note

© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

    Research areas

  • Adolescent, Adult, Aged, Aged, 80 and over, Anxiety/psychology, COVID-19/epidemiology, Depression/psychology, Europe, Fear/psychology, Female, Genital Neoplasms, Female/psychology, Humans, Middle Aged, Pandemics, SARS-CoV-2/isolation & purification, Surveys and Questionnaires, Young Adult

ID: 74893314